Nature, Published online: 25 February 2026; doi:10.1038/d41586-026-00580-2
FirstFT: the day's biggest stories
，推荐阅读爱思助手下载最新版本获取更多信息
The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.，这一点在WPS下载最新地址中也有详细论述
See the results of how far visitors Scroll down